LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Search

CareDx Inc

Avatud

SektorTervishoid

18.93 2.27

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.62

Max

19.06

Põhinäitajad

By Trading Economics

Sissetulek

10M

1.7M

Müük

13M

100M

P/E

Sektori keskmine

13.422

80.03

Kasumimarginaal

1.674

Töötajad

644

EBITDA

11M

6.8M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+26.98% upside

Turustatistika

By TradingEconomics

Turukapital

128M

914M

Eelmine avamishind

16.66

Eelmine sulgemishind

18.93

Uudiste sentiment

By Acuity

50%

50%

166 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Neutral Evidence

CareDx Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. dets 2025, 23:48 UTC

Suurimad hinnamuutused turgudel

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8. dets 2025, 23:44 UTC

Market Talk

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8. dets 2025, 23:42 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8. dets 2025, 23:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. dets 2025, 23:13 UTC

Market Talk

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8. dets 2025, 23:09 UTC

Omandamised, ülevõtmised, äriostud

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8. dets 2025, 22:46 UTC

Market Talk

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8. dets 2025, 22:01 UTC

Market Talk

Miners Poised to Do Well in 2026 -- Market Talk

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8. dets 2025, 21:51 UTC

Market Talk

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8. dets 2025, 21:50 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

8. dets 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. dets 2025, 21:38 UTC

Omandamised, ülevõtmised, äriostud

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8. dets 2025, 21:38 UTC

Omandamised, ülevõtmised, äriostud

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8. dets 2025, 21:36 UTC

Market Talk

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8. dets 2025, 21:20 UTC

Omandamised, ülevõtmised, äriostud

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8. dets 2025, 21:12 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8. dets 2025, 21:08 UTC

Market Talk

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8. dets 2025, 20:38 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8. dets 2025, 20:26 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8. dets 2025, 20:18 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8. dets 2025, 20:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8. dets 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8. dets 2025, 20:05 UTC

Market Talk

Global Equities Roundup: Market Talk

8. dets 2025, 20:05 UTC

Market Talk

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8. dets 2025, 20:01 UTC

Market Talk

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Võrdlus sarnastega

Hinnamuutus

CareDx Inc Prognoos

Hinnasiht

By TipRanks

26.98% tõus

12 kuu keskmine prognoos

Keskmine 24 USD  26.98%

Kõrge 26 USD

Madal 22 USD

Põhineb 4 Wall Streeti analüütiku instrumendi CareDx Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

4 ratings

2

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

14.77 / 18.49Toetus ja vastupanu

Lühikene perspektiiv

Neutral Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

166 / 374 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat